enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Treatment and management of COVID-19 - Wikipedia

   en.wikipedia.org/wiki/Treatment_and_management...

   This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]

3. COVID-19 drug repurposing research - Wikipedia

   en.wikipedia.org/wiki/COVID-19_drug_repurposing...

   The National Institutes of Health (NIH) COVID-19 Treatment Guidelines states "there is insufficient evidence to recommend either for or against the use of zinc for the treatment of COVID-19" and that "the Panel recommends against using zinc supplementation above the recommended dietary allowance for the prevention of COVID-19, except in a ...

4. COVID-19 drug development - Wikipedia

   en.wikipedia.org/wiki/COVID-19_drug_development

   [2] [16] Following a study published by The Lancet on safety concerns with hydroxychloroquine, the WHO suspended use of it from the Solidarity trial in May 2020, [197] [198] reinstated it after the research was retracted, [199] then abandoned further use of the drug for COVID-19 treatment when analysis showed in June that it provided no benefit ...

5. Nirmatrelvir/ritonavir - Wikipedia

   en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

   Nirmatrelvir/ritonavir has been evaluated in the treatment of COVID‑19 in standard-risk individuals in the EPIC-SR trial. [51] [53] This study did not achieve its primary goal of reducing time to sustained alleviation of COVID‑19 symptoms (treatment: 13 days (95% CI 12–15 days); placebo: 13 days (95% CI 11–14 days)).

6. Drug discovery research targeting COVID-19 will be topic of ...

   www.aol.com/drug-discovery-research-targeting...

   Research into a chemical compound that shows promise in stopping COVID-19 involved five nat'l labs and others, but led by Oak Ridge National Lab Drug discovery research targeting COVID-19 will be ...

7. Should you take a COVID-19 antiviral after getting infected ...

   www.aol.com/news/covid-19-antiviral-getting...

   “A brief return of symptoms may be part of the natural history of SARS-CoV-2 (the virus that causes COVID-19) infection in some persons, independent of treatment with Paxlovid and regardless of ...

8. Sipavibart - Wikipedia

   en.wikipedia.org/wiki/Sipavibart

   Sipavibart is an experimental medication under investigation for the prevention of COVID‑19 in people who are immunocompromised. [1] Sipavibart is a recombinant human IgG1 monoclonal antibody that provides passive immunization against SARS-CoV-2 by binding its spike protein receptor binding domain.

9. Some people are experiencing 'Paxlovid rebound' after taking ...

   www.aol.com/news/people-experiencing-paxlovid...

   When the antiviral medication Paxlovid was approved in 2021 to treat COVID-19, doctors began noticing a trend among some patients: a rebound case of the virus. After treatment, some people would ...